Conditions: Type 2 Diabetes
Keywords: Amylin Lilly exenatide once weekly thiazolidinedione metformin
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 134
Healthy volunteers: no

Brief summary:
This study will examine the safety of exenatide once weekly (2.0 mg) in approximately 134 patients receiving treatment with thiazolidinedione alone or thiazolidinedione in combination with metformin. Patients are expected to be treated with exenatide once weekly for at least 52 weeks.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: exenatide
Intervention descriptions: intervention 1: subcutaneous injection, 2.0mcg, once weekly

Protocol document: